| abstract |
The invention belongs to the field of medical technology, and relates to the crystal form of a compound as a mineralocorticoid receptor antagonist and a preparation method thereof, in particular to the compound 2-chloro-4-[(3S, 3aR)-3 shown in formula (1) ‑Cyclopentyl‑7‑(4‑hydroxypiperidine‑1‑carbonyl)‑3,3a,4,5‑tetrahydro‑2H‑pyrazolo[3,4‑f]quinolin‑2‑yl]benzene Preparation method of carbonitrile, crystal form thereof, preparation method of crystal form and application of crystal form thereof in preparation of medicine for treating and/or preventing kidney injury or cardiovascular disease Formula 1). |